Intelligent Bio Solutions logo
INBSIntelligent Bio Solutions
Trade INBS now
Intelligent Bio Solutions primary media

About Intelligent Bio Solutions

Intelligent Bio Solutions (NASDAQ:INBS) focuses on developing innovative solutions in the biosciences realm. The company's operations span across a variety of projects with objectives concentrated on harnessing biotechnology to address complex challenges in health, agriculture, and environment sectors. Despite the diversity of their portfolio, all projects are united by a common goal: to leverage scientific advancements for tangible, beneficial impacts in their target markets. While Intelligent Bio Solutions is currently traded exclusively on the NASDAQ under the ticker symbol INBS, its broad scope of activities and commitment to cutting-edge bioscience research underpin its vision to improve lives and foster sustainable practices globally.

What is INBS known for?

Snapshot

Public US
Ownership
2016
Year founded
51
Employees
New York, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
New York City, US

Products and/or services of Intelligent Bio Solutions

  • Development of innovative diagnostic tools aimed at enhancing rapid testing capabilities for infectious diseases, including COVID-19, to offer precise and swift results.
  • Production of advanced PCR (Polymerase Chain Reaction) testing kits which provide highly accurate detection of various pathogens, thus facilitating effective disease management and control.
  • Offering cutting-edge bioinformatics services that utilize data analytics and computational biology to support research in genomics, proteomics, and disease pathology.
  • Manufacturing of high-quality molecular diagnostics products that support laboratory operations in clinical diagnostics, including reagents and instruments critical for accurate testing.
  • Creation of a robust telemedicine platform that integrates health monitoring and diagnostic services, enabling remote healthcare delivery and patient management.
  • Providing comprehensive laboratory services ranging from routine blood tests to complex genetic testing, assisting healthcare providers in making informed treatment decisions.

Intelligent Bio Solutions executive team

  • Mr. Harry SimeonidisPresident & CEO
  • Mr. Spiro Kevin Sakiris B.Bus, C.A., Dip LawChief Financial Officer
  • Callistus SequeiraVice President of Global Quality & Operations
  • Mr. Doug HeathVice President of Global Sales
  • Anna TurkingtonVice President of Marketing

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.